SCHEMBL31678064

SCHEMBL31678064

CCc1nc2n(CC(=O)Nc3ccc(C(F)(F)F)cc3)c(C)c(Br)n2c(=O)c1-c1ccccc1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.38
▸ AKR1B1 P15121 1/20 0.37
▸ RORA P35398 1/20 0.36
▸ RORC P51449 1/20 0.36
▸ MEN1 O00255 5/20 0.36
▸ KMT2A Q03164 5/20 0.36
▸ KAT2B Q92831 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ POLB P06746 3/20 0.35
▸ FPR2 P25090 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ TRPA1 O75762 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ FPR1 P21462 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31678828 0.90 AKR1B1 (0.38) KDM4EAKR1B1RORARORCMEN1
SCHEMBL31678102 0.88 KDM4E (0.40) KDM4EAKR1B1MEN1KMT2AALDH1A1
SCHEMBL31678122 0.87 KMT2A (0.38) KDM4EAKR1B1RORARORCMEN1
SCHEMBL31678236 0.84 KDM4E (0.39) KDM4EAKR1B1RORCMEN1KMT2A
SCHEMBL31677892 0.82 KDM4E (0.43) KDM4EAKR1B1MEN1KMT2AFPR2
SCHEMBL31678727 0.82 AKR1B1 (0.41) KDM4EAKR1B1MEN1KMT2AALDH1A1
SCHEMBL31678842 0.79 KDR (0.37) KDM4EAKR1B1RORARORCMEN1
SCHEMBL31677868 0.78 RORC (0.40) KDM4EAKR1B1RORCMEN1KMT2A
SCHEMBL31678822 0.78 KDM4E (0.44) KDM4EAKR1B1MEN1KMT2AALDH1A1
SCHEMBL31678128 0.77 ACHE (0.45) KDM4EMEN1KMT2AALDH1A1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270218-A1 IMIDAZ0[1,2-A]PYRIMIDINE-5(1 H)-ONES AS WRN INHIBITORS INCYTE CORPORATION (US) 2025-08-28 — — US disclosed
US-20250270217-A1 IMIDAZ0[1,2-A]PYRIMIDINE-5(1 H)-ONES HAVING A COVALENT WARHEAD AT THE 3-POSITION AS WRN INHIBITORS INCYTE CORPORATION (US) 2025-08-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270217-A1 IMIDAZ0[1,2-A]PYRIMIDINE-5(1 H)-ONES HAVING A COVALENT WARHEAD AT THE 3-POSITION AS WRN INHIBITORS WRN, RECQL, BLM KDM4E 2390/4885AKR1B1 2548/4885RORA 1395/4885
US-20250270218-A1 IMIDAZ0[1,2-A]PYRIMIDINE-5(1 H)-ONES AS WRN INHIBITORS WRN, RECQL, BLM KDM4E 3187/4885AKR1B1 2350/4885RORA 2060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback